BSE Live
Dec 03, 16:02Prev. Close
1429.60
Open Price
1429.60
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Dec 03, 15:58Prev. Close
1430.90
Open Price
1439.60
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
1432.60 (27)
| Cash Flow of Tatva Chintan Pharma Chem (in Rs. Cr.) | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 | |
| 12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
| Net Profit/Loss Before Extraordinary Items And Tax | 7.58 | 43.57 | 44.78 | 104.12 | 60.70 | |
| Net CashFlow From Operating Activities | 24.67 | 98.04 | 27.78 | 20.38 | 24.32 | |
| Net Cash Used In Investing Activities | -65.25 | -120.54 | -101.14 | -196.81 | -21.01 | |
| Net Cash Used From Financing Activities | 16.57 | 30.52 | 37.80 | 234.96 | -8.80 | |
| Foreign Exchange Gains / Losses | 0.09 | -0.08 | -0.09 | 0.00 | 0.00 | |
| Adjustments On Amalgamation Merger Demerger Others | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Inc/Dec In Cash And Cash Equivalents | -23.93 | 7.94 | -35.65 | 58.54 | -5.49 | |
| Cash And Cash Equivalents Begin of Year | 35.30 | 27.37 | 63.02 | 4.48 | 10.83 | |
| Cash And Cash Equivalents End Of Year | 11.37 | 35.30 | 27.37 | 63.02 | 5.34 |
24.11.2025
Reduce Tatva Chintan Pharma Chem; target of Rs 1380: Deven Choksey
10.11.2025
Tatva Chintan Standalone September 2025 Net Sales at Rs 115.86 crore, up 43.11% Y-o-Y
31.10.2025
Tatva Chintan Consolidated September 2025 Net Sales at Rs 123.52 crore, up 47.94% Y-o-Y
03.09.2025
Sell Tatva Chintan Pharma Chem; target of Rs 860: Deven Choksey
10.11.2025
Tatva Chintan Standalone September 2025 Net Sales at Rs 115.86 crore, up 43.11% Y-o-Y
31.10.2025
Tatva Chintan Consolidated September 2025 Net Sales at Rs 123.52 crore, up 47.94% Y-o-Y
25.07.2025
Tatva Chintan Consolidated June 2025 Net Sales at Rs 116.86 crore, up 10.81% Y-o-Y
25.07.2025
Tatva Chintan Standalone June 2025 Net Sales at Rs 109.18 crore, up 16.39% Y-o-Y